Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Sanofi and Google partner to improve diabetes treatment Sanofi and Google will work together on new digital technology and tools for enhancing the management and treatment of diabetes.
Contract Research & Services > Contract Research > News
ESC launches new concept for driving innovation in cardiovascular research with support from Boehringer The European Society of Cardiology (ESC) announced the launch of the competitive medical research programme ‘ESC Grants for Medical Research Innovation’, exclusively supported by an independent grant from Boehringer Ingelheim.
Contract Research & Services > Contract Research > News WuXi PharmaTech's STA subsidiary gets first approval from Japanese regulatory authorities WuXi PharmaTech (Cayman), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, announced that its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical (STA) received its first approval from the Japan PMDA for the manufacture of the GMP intermediate of a branded commercial drug in July.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
WuXi PharmaTech's STA subsidiary gets first approval from Japanese regulatory authorities
WuXi PharmaTech (Cayman), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, announced that its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical (STA) received its first approval from the Japan PMDA for the manufacture of the GMP intermediate of a branded commercial drug in July.
Contract Research & Services > Contract Research > News
Biolab to open new R&D centre in Greater Toronto Area
By PBR Staff Writer
Brazilian pharmaceutical firm Biolab Farmacêutica is opening a new research and development (R&D) centre in the Greater Toronto Area in Canada.
Contract Research & Services > Contract Research > News
Enumeral, UMass Medical School enter into research study agreement
Enumeral Biomedical Holdings (ENUM) announced that it has entered into a research study agreement with University of Massachusetts Medical School (UMMS), which includes that institution’s clinical partner, UMass Memorial Health Care, Inc.
Contract Research & Services > Contract Research > News
Clementia enrols children in ongoing Phase II trial of palovarotene to treat FOP
By PBR Staff Writer
Canada-based Clementia Pharmaceuticals has started enrolling children aged six years in its ongoing Phase II trial of palovarotene to treat fibrodysplasia ossificans progressiva (FOP), an extremely rare and severely disabling congenital myopathy.
Contract Research & Services > Contract Research > News
Arbutus begins dosing in Phase IIa expansion group trial of TKM-PLK1 to treat HCC
By PBR Staff Writer
Canadian biopharmaceutical firm Arbutus Biopharma has started dosing in a 20 subject expansion group of a Phase IIa clinical trial of TKM-PLK1 for the treatment of hepatocellular carcinoma (HCC).
Contract Research & Services > Contract Research > News
CSL Behring begins enrollment in Phase II/III trial of rVIIa-FP to treat hemophilia A or B
By PBR Staff Writer
CSL Behring has started enrolling patients in its Phase II/III clinical trial of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B.
Contract Research & Services > Contract Research > News
Eisai reports positive Phase III trial results for FYCOMPA
Eisai announced that the results of its Phase 3 trial (Study 332) for FYCOMPA (perampanel) CIII have been published in the online edition of Neurology, the medical journal of the American Academy of Neurology.
Contract Research & Services > Contract Research > News
Accutest expands into Latin American countries to support drug development
Accutest Research Laboratories, a leading global Contract Research Organization (CRO), further pursues its strategic expansion into Latin America by opening offices and establishing operational presence in Brazil.
Contract Research & Services > Contract Research > News
DelMar gets additional non-dilutive funding from NRC-IRAP to support expanded research program with VAL-083
DelMar Pharmaceuticals (DMPI), a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, announced an increase in funding of up to CDN$287,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to support an ongoing research project.
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests